Support Line: 0800 002 9002
General Enquiries: 01223 870008
Donate

News Archive

Sorafenib

Tivozanib Approved in Europe for Kidney Cancer

Tivozanib Approved in Europe for Kidney Cancer

Sorafenib| Tivozanib
The European Commission (EC) has approved tivozanib (Fotivda) for the treatment of patients with advanced renal ...
Hopes for Cabozantinib NICE recommendation

Hopes for Cabozantinib NICE recommendation

Cabozantinib| NICE| Sorafenib
Kidney Cancer UK is very disappointed to hear that at the midpoint of the Single Technology Appraisal (STA) of ...
Major changes to the current Cancer Drugs Fund

Major changes to the current Cancer Drugs Fund

Sorafenib
As previously reported, some major changes to the current Cancer Drugs Fund (CDF) are due to be reported this ...
Cancer Drugs Fund changes and what it could mean to you

Cancer Drugs Fund changes and what it could mean to you

Sorafenib
Changes to Cancer Drug Fund in April 2016. Currently the Cancer Drug Fund (CDF) enables health professionals to ...
Sunitinib and Sorafenib trial in locally advanced renal cell carcinoma

Sunitinib and Sorafenib trial in locally advanced renal cell carcinoma

Clinical Trials| Sorafenib| Sunitinib
Currently the targeted therapy drugs Sunitinib and Sorafenib are widely used in the UK for use in metastatic renal ...